
Noah Federman MD Professor Health Sciences
Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Director, UCLA Pediatric Bone and Soft Tissue Sarcoma Program Director, UCLA CTSI - Clinical and Translational Research Center Director, UCLA CIRM Alpha Stem Cell Clinic Professor, Department of Pediatrics and Orthopaedic Surgery, UCLA School of Medicine
Join to View Full Profile
10833 Le Conte Ave., A2-410 MDCLos Angeles, CA 90095
Phone+1 310-825-6708
Fax+1 310-825-6708
Dr. Federman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2002 - 2005
- Icahn School of Medicine at Mount SinaiClass of 2002
- Williams CollegeB.A., English and Neuroscience, 1993 - 1997
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- 2021 Los Angeles Magazine Top Doctors 2021
- Voted Southern California Rising Star SuperDoctors.com, 2015
- Voted Best Doctors BestDoctors.com, 2014
- Join now to see all
Clinical Trials
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Start of enrollment: 2014 Feb 01
- A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children Start of enrollment: 2015 Dec 16
- TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsElective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.Leo Mascarenhas, Steven G DuBois, Catherine M Albert, Stefan Bielack, Daniel Orbach
Journal of Clinical Oncology. 2025-04-01 - Achieving durable response with the TRK inhibitor larotrectinib, and possible discontinuation of therapy in pediatric NTRK gene fusion-positive solid tumors.Noah Federman, Camille Hamilton
Clinical Advances in Hematology & Oncology. 2025-04-01 - Orbital indeterminate cell histiocytosis.Angela J Oh, Connie M Sears, Akhila A Vadivelan, Brigitte N Gomperts, Noah Federman
Orbit. 2025-02-01
Journal Articles
- Percutaneous Image guided core needle biopsies in children with bone and soft tissue tumorsMitton B, Seeger LL, Eckardt MA, Motamedi K, Nelson SD, Eilber FC, Eckardt JJ, Federman N, J Pediatr Hematol Oncol, 1/1/2014
- Giant cell tumor of bone in childhood: Clinical aspects and novel therapeutic targets Invited reviewFederman N, Breyen E, Narasimhan V, Sodhi M, Dry SM, Chawla SP, Paediatr Drugs, 1/1/2014
- Safety and efficacy of stereotactic body radiation therapy for pulmonary metastases from high-grade sarcomasMehta NM, Selch M, Federman N, Chmielowski B, Lee JM, Eilber FC, Wang P, Wu J, Agazaryan N, Lee P, Sarcoma, 1/1/2013
- Join now to see all
Abstracts/Posters
- Sclerostin expression and biologic function in skeletal sarcomas.Shen J, Shrestha S, La Chaud G, Asatrian G, Singh A, Federman N, Dry SM, Ting K, Chia S, James AW, Orthopedic Research Society Annual Meeting, 1/1/2016
- Malignant transformation of dysplasia epiphysealis hemimelica (Trevor’s disease): The first reported case and recommendations for surveillance.Calvert G, Sato J, Federman N, Singh A, Femino D, Musculoskeletal Tumor Society Annual Meeting, 1/1/2015
- A novel mutation in the HARS gene in a patient with infantile myofibromatosis.Baca N, Walsh A, Nelson SF, Federman N, Chang VY, American Society of Pediatric Hematology/Oncology Annual Meeting, 1/1/2015
- Join now to see all
Lectures
- Successful patient recruiting, consenting and retention on pediatric clinical trials.1/1/2015
- Approaches to Death and Dying in the Pediatric Oncology Patient.1/1/2015
- Osteosarcoma- what the orthopaedic surgeon needs to know.1/1/2015
- Join now to see all
Other
- Nonrhabdomyosarcoma Soft Tissue Sarcomas.Walker JK, Crouch GD, Federman N, eMedicine from WebMD
http://emedicine.medscape.com/article/991351-overview
1/4/2012 - Thrombasthenia.Chang VY, Green ME, Frankel LS, Federman N, eMedicine from WebMD
http://emedicine.medscape.com/article/955385-overview
1/10/2011 - Primary cardiac osteosarcoma with metastasis to the thyroid: Case report.Mitton B, Federman N, Pediatric News, AAP Newsletter, Spring
1/1/2009
Press Mentions
- Case Report Highlights Promising Approach for Treating Pediatric Thyroid CancerFebruary 7th, 2025
- Drug Safe for Long-Term Use in Kids with Rare Cancer, Study FindsFebruary 4th, 2025
- Unlocking the Potential of Patient-Derived Organoids for Personalized Sarcoma TreatmentSeptember 20th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: